Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.
Maliah A, Santana-Magal N, Parikh S, Gordon S, Reshef K, Sade Y, Khateeb A, Richter A, Gutwillig A, Parikh R, Golan T, Krissi M, Na M, Binshtok G, Manich P, Elkoshi N, Grisaru-Tal S, Zemser-Werner V, Brenner R, Vaknine H, Nizri E, Moyal L, Amitay-Laish I, Rosemberg L, Munitz A, Kronfeld-Schor N, Shifrut E, Kobiler O, Madi A, Geiger T, Carmi Y, Levy C.
Maliah A, et al. Among authors: carmi y.
Nat Commun. 2024 Sep 27;15(1):8354. doi: 10.1038/s41467-024-52079-x.
Nat Commun. 2024.
PMID: 39333093
Free PMC article.